Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

MOR103 – Antibody for the Treatment of Rheumatoid Arthritis

Drug (brand/generic)

MOR103

Company / licensee

MorphoSys

Therapy class

Immunosuppressive agent

Product description

Human HuCAL Antibody

Current indication

Rheumatoid Arthritis

Market sector

Rheumatology

Development status

Phase II
Expand

Go Top